Manuka honey and its component, methyl syringate, shift neutrophil release profiles from pro-inflammatory while preserving pro-regenerative growth factor release in vitro

In conclusion, the data suggest that Manuka honey and methyl syringate are both efficacious at reducing pro-inflammatory cytokines and enzymes. However, methyl syringate alone preserved factors associated with pro-angiogenic and remodeling despite reduced inflammation.